Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**lactobacillus fermentum + vitamin d3** is a combination of a probiotic, *Limosilactobacillus fermentum* (formerly known as *Lactobacillus fermentum*), and vitamin D3 (cholecalciferol). This combination is typically marketed as a dietary supplement and not as a pharmaceutical drug. The probiotic component supports gut health, influences the microbiome composition, and can modulate inflammatory responses. Vitamin D3 acts primarily as an immunomodulator, regulating calcium and phosphorus metabolism, and also modulates inflammatory cytokines. Evidence suggests synergistic benefits for immune, metabolic, and cognitive health, including reduced inflammation, improved epithelial barrier function, and enhanced physical performance, especially in certain populations such as athletes and those with specific diseases[3][5][6]. Studies show that combining vitamin D3 with probiotics (such as *Lactobacillus fermentum*) can improve the anti-inflammatory response, possibly by downregulating proinflammatory cytokines and improving gut epithelial cell permeability[1][5]. This combination is most commonly considered and used as a dietary supplement.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lactobacillus fermentum + vitamin d3.